Mylan NV

Mylan NV

Mylan NV

Overview
Date Founded

2014

Headquarters

Trident Place,Mosquito Way,Building 4,Hatfield, Hertfordshire AL10 9UL

Type of Company

Public

Employees (Worldwide)

35K

Industries

Pharmaceuticals

Company Description

Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.

Website
Executives & Employees

Chief Executive Officer & Executive Director

Executive Chairman Executive Director

President & Director

Chief Financial Officer

Chief Financial Officer & Executive Vice President

Chief Commercial Officer

Chief Accounting Officer & Senior Vice President

Secretary

Head-Global Research & Development

Vice President & Head-eCommerce

Board of Directors

Former President & Chief Executive Officer at International Federation of Pharmaceutical Wholesalers

Chief Executive Officer & Executive Director at Mylan NV

Former Chief Financial Officer & Executive Vice President at AmerisourceBergen Corporation

Director-Allegheny District Chapter at National Multiple Sclerosis Society

President & Director at Mylan Pharmaceuticals, Inc.

Former Partner at Deloitte & Touche LLP

Senior Advisor at Mylan Pharmaceuticals, Inc.

Former President at Mylan Pharmaceuticals, Inc.

Paths to Mylan NV
Potential Connections via
Relationship Science
You
Mylan NV
Owners & Shareholders
Details Hidden

Pzena Investment Management is a global investment management firm that employs a classic value investment approach. The firm began managing assets on January 1, 1996. Our solid return record and reputation for business integrity, research excellence, and devotion to our investment philosophy has led to significant growth in our business. As of February 28, 2013, the firm managed $18.9 billion in assets for leading corporate, public, and individual clients. Our team is made up of 69 employees. Our headquarters is in New York City, with a representative office in Melbourne, Australia.

Details Hidden

Slate Path Capital seeks to achieve risk-adjusted capital growth over the long-term through a fundamental, research-based, security selection process. The funds that invest in Slate Path's Flagship Master Fund are global long-short funds that focus primarily on equities but also have significant non-equity positions. The funds that invest in the SPJ Master Fund are long-short funds that focus on Japanese securities, securities in or related to the Chinese capital markets, and other themes pursued by the Flagship Master Fund. The funds' portfolios include both long and short positions. Investments include a variety of equity- or debt-related instruments, including equity and non-equity-related derivatives, swaps, options, commodities, foreign currency, futures and forward contracts, as well as any other instruments Slate Path deems appropriate in order to seek to both maximize returns and minimize risks. The funds employ significant leverage, take concentrated positions and may experience significant volatility as part of their strategy.

Details Hidden

Paulson's investment strategies are all based on the same underlying investment philosophy of capital preservation and low correlation to the broad markets. They perform fundamental and legal analysis on investments, including reviews of company financials and review of legal documentation related to proposed investment opportunities. The firm's products are provided through collective investment vehicles, including both domestic partnerships and offshore private investment companies, and separately managed accounts that deploy all or a subset of the firm's investment strategies. Paulson's investment objective is to achieve positive excess returns through trading the securities and/or derivatives thereon of companies that are the subject of proposed changes in corporate structure or control such as tender offers, mergers, spin-offs, proxy contests, liquidations, recapitalizations, restructurings and bankruptcy reorganizations.

Recent Transactions
Details Hidden

Mylan NV, Mylan (Pty.) Ltd. purchase Ascendis Health International (Pty) Ltd. from Ascendis Health Ltd.

Details Hidden

Mylan NV purchases Apicore US LLC from Medicure, Inc.

Details Hidden

Cytovia, Inc., Immune Pharmaceuticals Inc purchase Meda Pharma SARL /Ceplene Bus from Mylan NV

Transaction Advisors
Legal Advisor

Advised onMylan NV purchases Meda AB

Legal Advisor

Advised onMylan NV purchases Meda AB

Legal Advisor

Advised onMylan NV purchases Meda AB

Legal Advisor

Advised onMylan NV purchases Meda AB

Associate

Advised onMylan NV purchases Meda AB

Legal Advisor

Advised onMylan NV purchases Meda AB

Advisors & Consultants
Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Advisor

Chief Financial Officer & Senior Vice President at Terex Corp.

Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Clients

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.

McKesson is dedicated to delivering the vital medicines, medical supplies and information technologies that enable the health care industry to provide patients better, safer care. McKesson is made up of many businesses, all serving the health care industry. Our businesses fall into one of two primary categories: Distribution solutions. We are the largest pharmaceutical distributor in North America, distributing one-third of the medicines used every day. As one of the leading pharmaceutical companies, we supply more than 40,000 U.S. pharmacy locations, from Wal-Mart to the Department of Veterans Affairs to community pharmacies and hospitals. McKesson is also one of the leading medical supply companies and distributes medical-surgical supplies and homecare supplies. Healthcare Technology solutions. We develop and install healthcare information technology systems that eliminate the need for paper prescriptions and paper medical records. Our software and hardware are used in more than 70% of the nation's hospitals with more than 200 beds. Our hospital information system solutions include electronic health record system (EHR) and clinical decision support system such as Interqual. McKesson's Healthcare IT division also serves diverse areas within the health industry by offering solutions such as pharmacy automation and medical claims management software. McKesson publicly traded on NYSE under MCK Businesses Serving our customers—pharmacies, medical and pharmaceutical manufacturers, hospitals, and insurers—as the health care industry evolves is our primary goal. We have business lines to automate processes from medical supplies packaging to claims management, and revenue cycle management to medical imaging. McKesson's long history in pharmaceutical industry History McKesson has a long history in health care. We’ve been a trusted provider of medical supplies and goods for more than 175 years.

Key Stats and Financials As of 2019
Market Capitalization
$8.34B
Total Enterprise Value
$22.7B
Earnings Per Share
$0.03
Revenue
$11.5B
Enterprise Value Sales
1.97x
TEVNet Income
1,351.53x
Debt TEV
0.57x
Total Equity
$11.9B
Total Debt
$12.9B
Net Profit
$16.8M
EBITDAMargin
24.54%
Enterprise Value EBITDAOperating
7.96x
EBITDA
$2.82B
Five Year Compounded Annual Growth Rate Of Revenue
8.17%
Three Year Compounded Annual Growth Rate Of Revenue
1.13%
Non-Profit Donations & Grants
Investors
Details Hidden

Founder at Icahn Enterprises LP

Suppliers
Aceto Corp. Medical Products & Equipment | Port Washington, NY

Aceto functions as a virtual manufacturing company, distributing more than 1,100 chemical compounds used principally as raw materials or finished products. With business operations in nine countries, Aceto’s global reach is distinctive in the industry, enabling the Company to source and supply quality products on a worldwide basis. Leveraging local professionals, Aceto sources more than two-thirds of its products from Asia, buying from approximately 500 companies in China and 200 in India.

UniFirst Corp. Apparel & Footwear | Wilmington, MA

UniFirst Corp. engages in the design, manufacture, personalization, rental, cleaning, delivery, and sale of a range of uniforms and protective clothing. It operates through following segments: U.S. Rental and Cleaning, Canadian Rental and Cleaning, Manufacturing, Specialty Garments Rental and Cleaning, First Aid, and Corporate. The U.S. and Canadian Rental and Cleaning segment purchases, rents, cleans, delivers and sells uniforms and protective clothing and non-garment items in the United States and Canada. The Manufacturing segment designs and manufactures uniforms and non-garment items primarily for the purpose of providing these goods to the U.S. and Canadian Rental and Cleaning reporting segment. The Specialty Garments Rental and Cleaning segment sells specialty garments and non-garment items primarily for nuclear and cleanroom applications and provides cleanroom cleaning services at limited customer locations. The First Aid segment provides first aid cabinet services and other safety supplies as well as maintains wholesale distribution and pill packaging operations. The Corporate segment consists of costs associated with its distribution center, sales and marketing, information systems, engineering, materials management, manufacturing planning, finance, budgeting, human resources, other general and administrative costs and interest expense. The company was founded by Aldo Croatti in 1936 and is headquartered in Wilmington, MA.

Pfizer, Inc. Medical Support Services | New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Mylan NV. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Mylan NV's profile does not indicate a business or promotional relationship of any kind between RelSci and Mylan NV.